QT Imaging Holdings, Inc. (NASDAQ:QTI – Get Free Report) was the recipient of a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 233,079 shares, a decline of 53.0% from the May 14th total of 495,661 shares. Based on an average trading volume of 54,372 shares, the short-interest ratio is presently 4.3 days. Currently, 2.7% of the shares of the company are sold short.
QT Imaging Price Performance
NASDAQ:QTI traded up $0.05 during trading hours on Friday, reaching $4.04. The company had a trading volume of 48,165 shares, compared to its average volume of 73,948. The stock has a 50-day moving average of $5.89 and a two-hundred day moving average of $5.93. QT Imaging has a one year low of $0.75 and a one year high of $8.50. The firm has a market capitalization of $48.64 million, a PE ratio of -3.26 and a beta of -0.08. The company has a quick ratio of 1.69, a current ratio of 2.49 and a debt-to-equity ratio of 1.38.
QT Imaging (NASDAQ:QTI – Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.11). QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%. The company had revenue of $6.53 million during the quarter, compared to the consensus estimate of $6.45 million. Analysts forecast that QT Imaging will post -0.59 earnings per share for the current year.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on QT Imaging
QT Imaging Company Profile
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Featured Stories
- Five stocks we like better than QT Imaging
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
